Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation

Compound Kushen Injection (CKI) is a Traditional Chinese Medicine (TCM) preparation that has been clinically used in China to treat various types of solid tumours. Although several studies have revealed that CKI can inhibit the proliferation of hepatocellular carcinoma (HCC) cell lines, the active c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Li, Wang, Ke-xin, Zhou, Yu-zhi, Fang, Jian-song, Qin, Xue-mei, Du, Guan-hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766629/
https://www.ncbi.nlm.nih.gov/pubmed/29330507
http://dx.doi.org/10.1038/s41598-017-18325-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766629/
https://www.ncbi.nlm.nih.gov/pubmed/29330507
http://dx.doi.org/10.1038/s41598-017-18325-7

Ejemplares similares